ArriVent BioPharma (AVBP) Stock Chart & Stock Price History → Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad) Free AVBP Stock Alerts $18.34 -0.21 (-1.13%) (As of 03:58 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends ArriVent BioPharma Stock Price Performance5 Day Performance-1.77%1 Month Performance+3.62%3 Month Performance-6.48% Receive AVBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss Ratings[URGENT] DO NOT Touch These AI Stocks!Artificial intelligence stocks are carrying the market. One of them, Nvidia, recently became the seventh company ever to hit a $1 trillion market cap. But is this AI rally over?Click here for our #1 AI Stock for 2024 and Beyond AVBP Stock Chart for Monday, June, 10, 2024 AVBP Chart by TradingView ArriVent BioPharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$18.35$18.55+1.09%$19.31$17.9419,083 shs$621.24 million06/06/2024$18.67$18.35-1.71%$19.05$18.1712,666 shs$614.54 million06/05/2024$18.33$18.67+1.85%$18.98$18.4228,103 shs$613.95 million06/04/2024$19.19$18.33-4.48%$19.58$18.0441,968 shs$613.87 million06/03/2024$19.41$19.19-1.13%$19.83$18.4041,204 shs$642.67 million05/31/2024$19.46$19.41-0.26%$20.25$19.1681,837 shs$650.04 million Get the Latest News and Ratings for AVBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$18.78$19.46+3.62%$19.86$19.0049,639 shs$651.72 million05/29/2024$18.97$18.78-1.00%$19.17$18.4421,130 shs$628.94 million05/28/2024$19.24$18.97-1.40%$19.66$18.7045,529 shs$635.31 million05/27/2024$19.24$19.24$19.24$18.1281,000 shs$644.35 million05/24/2024$18.88$19.24+1.91%$19.24$18.1281,061 shs$644.35 million05/23/2024$19.89$18.88-5.08%$20.13$18.7521,554 shs$632.29 million05/22/2024$19.95$19.89-0.30%$21.00$19.8159,222 shs$666.20 million05/21/2024$19.58$19.95+1.89%$20.34$19.6941,194 shs$668.13 million05/20/2024$20.10$19.58-2.59%$20.40$19.2940,311 shs$655.73 million05/17/2024$20.15$20.10-0.25%$20.85$19.9965,380 shs$673.15 million05/16/2024$19.50$20.15+3.33%$20.74$19.3056,995 shs$674.82 million05/15/2024$18.46$19.50+5.63%$19.55$18.7451,360 shs$653.06 million05/14/2024$17.93$18.46+2.96%$18.80$17.6839,373 shs$618.23 million05/13/2024$17.70$17.93+1.30%$18.51$16.9747,943 shs$600.48 million05/10/2024$17.99$17.70-1.61%$18.00$17.3927,905 shs$592.84 million05/09/2024$17.36$17.99+3.63%$17.99$17.3630,615 shs$602.56 million05/08/2024$17.25$17.36+0.64%$17.85$16.8240,811 shs$581.46 million05/07/2024$17.24$17.25+0.06%$17.62$17.0241,505 shs$577.77 million05/06/2024$17.23$17.24+0.06%$17.63$16.9325,226 shs$577.37 million05/03/2024$16.80$17.23+2.56%$17.51$16.7623,943 shs$577.03 million05/02/2024$16.69$16.80+0.66%$17.39$16.5462,370 shs$562.70 million05/01/2024$16.52$16.69+1.03%$17.42$15.7965,808 shs$558.95 million04/30/2024$16.34$16.52+1.10%$16.96$15.66108,462 shs$553.26 million04/29/2024$15.44$16.34+5.83%$16.64$15.3652,617 shs$547.23 million04/26/2024$15.54$15.44-0.64%$16.47$15.4053,529 shs$517.09 million04/25/2024$15.30$15.54+1.57%$15.88$14.3568,890 shs$520.44 million04/24/2024$15.77$15.30-2.98%$16.08$14.75130,345 shs$512.40 million04/23/2024$15.90$15.77-0.82%$16.29$15.3186,950 shs$528.20 million04/22/2024$15.50$15.90+2.58%$16.65$15.60115,535 shs$532.49 million04/19/2024$15.50$15.50$16.26$15.1734,155 shs$519.10 million04/18/2024$16.04$15.50-3.37%$17.04$14.74629,988 shs$519.10 million04/17/2024$16.80$16.04-4.52%$16.93$15.50194,788 shs$537.18 million04/16/2024$17.00$16.80-1.18%$17.55$16.44258,462 shs$562.63 million04/15/2024$16.89$17.00+0.65%$17.35$16.55311,965 shs$569.33 millionProtect Your Bank Account Before It’s Too Late (Ad)For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself04/12/2024$17.67$16.89-4.41%$17.85$16.6797,650 shs$565.65 million04/11/2024$17.29$17.67+2.20%$17.95$17.1071,831 shs$591.77 million04/10/2024$17.33$17.29-0.23%$17.66$16.9196,319 shs$579.04 million04/09/2024$17.49$17.33-0.91%$17.83$17.15132,269 shs$580.45 million04/08/2024$18.45$17.49-5.20%$18.54$17.34137,708 shs$585.74 million04/05/2024$18.30$18.45+0.82%$18.98$18.1241,494 shs$617.89 million04/04/2024$18.12$18.30+0.99%$18.54$17.8577,510 shs$612.94 million04/03/2024$18.00$18.12+0.67%$18.20$17.87122,190 shs$606.84 million04/02/2024$18.31$18.00-1.69%$18.20$17.92138,099 shs$575.28 million04/01/2024$17.86$18.31+2.52%$19.11$17.74357,779 shs$585.19 million03/29/2024$17.86$17.86$18.30$17.73233,160 shs$570.75 million03/28/2024$18.00$17.86-0.78%$18.30$17.73233,160 shs$570.81 million03/27/2024$17.80$18.00+1.12%$18.31$17.50121,847 shs$575.28 million03/26/2024$16.96$17.80+4.95%$18.04$16.91132,790 shs$568.89 million03/25/2024$18.28$16.96-7.22%$18.22$16.90121,475 shs$542.04 million03/22/2024$18.21$18.28+0.38%$18.46$17.8484,716 shs$584.23 million03/21/2024$18.42$18.21-1.14%$18.51$17.58172,738 shs$581.99 million03/20/2024$18.13$18.42+1.60%$18.67$17.67178,129 shs$588.70 million03/19/2024$18.55$18.13-2.26%$18.57$17.65298,818 shs$579.38 million03/18/2024$19.49$18.55-4.82%$19.78$18.14301,289 shs$592.86 million03/15/2024$18.57$19.49+4.95%$20.15$18.281.97 million shs$622.90 million03/14/2024$19.75$18.57-5.97%$19.75$17.69261,998 shs$593.50 million03/13/2024$19.15$19.75+3.13%$19.83$19.02149,831 shs$631.21 million03/12/2024$19.33$19.15-0.93%$19.96$18.75159,785 shs$612.03 million03/11/2024$19.61$19.33-1.43%$20.32$19.10111,746 shs$617.79 million Related Companies: TG Therapeutics Stock Chart Rhythm Pharmaceuticals Stock Chart Indivior Stock Chart Geron Stock Chart Bausch Health Companies Stock Chart Deciphera Pharmaceuticals Stock Chart Janux Therapeutics Stock Chart Maravai LifeSciences Stock Chart Rocket Pharmaceuticals Stock Chart Vera Therapeutics Stock Chart Receive AVBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVBP) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ArriVent BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ArriVent BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.